Rilmenidine treatment in patients with mild to moderate arterial hypertension and metabolic syndrome

Rilmenidine treatment in patients with mild to moderate arterial hypertension and metabolic syndrome

Efficacy, tolerability and cardioprotective properties of rilmenidine were examined in patients with mild to moderate arterial hypertension (AH). The trial involved 51 hypertensive subjects, mean age 57,7+2,5 years. After wash-out period, rilmenidine was administered in the daily dose of 1-2 mg. At...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän:	S. S. Yakushin, N. I. Ivankova, N. S. Sazonova, N. V. Vilesova, G. O. Ivanova
Materialtyp:	Artikel
Språk:	Russian
Publicerad:	«FIRMA «SILICEA» LLC 2004-12-01
Serie:	Российский кардиологический журнал
Ämnen:	arterial hypertension metabolic syndrome cardioprotective effects rilmenidine
Länkar:	https://russjcardiol.elpub.ru/jour/article/view/2326

Liknande verk

EFFECT OF ANTIHYPERTENSIVE THERAPY WITH RILMENIDINE ON COGNITIVE FUNCTION IN ELDERLY HYPERTENSIVE PATIENTS
av: S. V. Nedogoda, et al.
Publicerad: (2016-01-01)

ASSESSMENT OF RILMENIDINE EFFICIENCY IN PATIENTS WITH ARTERIAL HYPERTENSION WITH DETERIORATION OF DAILY PROFILE OF BLOOD PRESSURE
av: P. P. Tikhonov, et al.
Publicerad: (2015-12-01)

Perspectives of decreasing individual cardiovascular risk in high- and very high risk patients with arterial hypertension, treated with rilmenidine
av: S. V. Nedogoda, et al.
Publicerad: (2005-06-01)

Workplace arterial hypertension: potential of rilmenidine-based combination therapy
av: S. I. Drozdetsky, et al.
Publicerad: (1970-01-01)

Rilmenidine treatment in hypertensive patients with cerebrovascular transient ischemic attacks
av: A. P. Kondrakhin, et al.
Publicerad: (2005-10-01)

Rilmenidine therapy potential in pharmaceutical correction of endothelial dysfunction among women with arterial hypertension, Type 2 diabetes mellitus, and visceral obesity
av: E. V. Eliseeva, et al.
Publicerad: (1970-01-01)

THE WAYS OF SYMPATHETIC SYSTEM OVERACTIVITY BLOCKING: RILMENIDINE VERSUS ATENOLOL
av: Y. R. Kasherininov, et al.
Publicerad: (2016-01-01)

Autophagy and anti-inflammation ameliorate diabetic neuropathy with Rilmenidine
av: Mehmet Burak Yalçın, et al.
Publicerad: (2023-12-01)

Rilmenidine Protects Against Joint Damage in MIA-induced Model of Osteoarthritis in Rats
av: Osman Kukula, et al.
Publicerad: (2024-02-01)

Main results of the Russian trial «ALTAIR»
av: E. V. Shlyakhto, et al.
Publicerad: (2006-02-01)

Comparison in conscious rabbits of the baroreceptor-heart rate reflex effects of chronic treatment with rilmenidine, moxonidine, and clonidine
av: Monique L Parkin, et al.
Publicerad: (2016-11-01)

ARTERIAL HYPERTENSION IN YOUNG PEOPLE: EFFICACY OF SYMPATHOLYTIC THERAPY
av: N. N. Nikitina, et al.
Publicerad: (2015-12-01)

Effects of centrally acting antihypertensive drugs on the microcirculation of spontaneously hypertensive rats
av: V. Estato, et al.
Publicerad: (2004-10-01)

PHARMACEUTICAL CORRECTION OF VASCULAR DISTURBANCES IN PATIENTS WITH ARTERIAL HYPERTENSION
av: L. A. Khaisheva, et al.
Publicerad: (2010-10-01)

Combined treatment of arterial hypertension: focus on calcium antagonist and ACE inhibitor combination
av: V. I. Makolkin
Publicerad: (2008-12-01)

Not first‐line antihypertensive agents, but still effective—The efficacy and safety of imidazoline receptor agonists: A network meta‐analysis
av: András Érszegi, et al.
Publicerad: (2024-06-01)

Cerebral blood flow and blood rheology in hypertensive patients during rilmenidine treatment
av: L. I. Markova, et al.
Publicerad: (2004-06-01)

BISOPROLOL AND METFORMIN IN PATIENTS WITH ARTERIAL HYPERTENSION AND METABOLIC SYNDROME
av: V. A. Nevzorova, et al.
Publicerad: (2015-12-01)

Prevalence of metabolic syndrome and its components in patients with arterial hypertension and obesity
av: I. E. Chazova, et al.
Publicerad: (2005-12-01)

Valsartan effects on platelet activity in patients with arterial hypertension and metabolic syndrom
av: I. N. Medvedev, et al.
Publicerad: (2007-06-01)

Reduced platelet aggregation in losartan-treated patients with arterial hypertension and metabolic syndrome
av: I. N. Medvedev, et al.
Publicerad: (2008-10-01)

Eprosartan effects on intravascular platelet activity in patients with arterial hypertension and metabolic syndrome
av: I. N. Medvedev, et al.
Publicerad: (2008-02-01)

Intravascular platelet activity correction by fosinopril in arterial hypertension patients with metabolic syndrome
av: I. N. Medvedev, et al.
Publicerad: (2006-10-01)

Microcirculatory function in patients with arterial hypertension, metabolic syndrome and diabetes mellitus
av: A. P. Vasilyev, et al.
Publicerad: (2008-10-01)

Some hormonal systems in males with arterial hypertension and metabolic syndrome
av: A. N. Britov, et al.
Publicerad: (2006-06-01)

CORRECTION OF AGGREGATIVE FUNCTION OF THE TROMBOCYTES IN ARTERIAL HYPERTENSION PATIENTS WITH METABOLIC SYNDROM UNDER THE INFLUENCE OF SIMVASTATINE
av: N. J. Gromnazky, et al.
Publicerad: (2003-12-01)

Metabolic syndrome in patients with arterial hypertension living in the Far North (on the example of the Khanty-Mansi Autonomous Okrug — Yugra)
av: E. G. Ivanova, et al.
Publicerad: (2023-04-01)

The comorbid patients with arterial hypertension, chronic heart failure and chronic kidney disease: the role of fosinoprile
av: G. N. Gorokhovskaya, et al.
Publicerad: (2018-04-01)

Arterial hypertension and metabolic syndrome: specifics of antihypertensive therapy
av: L. I. Abasova, et al.
Publicerad: (2011-08-01)

Features of the clinical course of arterial hypertension in alien residents of Western Siberia with the establishment of patterns of metabolic changes
av: E. G. Ivanova, et al.
Publicerad: (2022-07-01)

Spirapril effects on heart remodeling in patients with mild to moderate arterial hypertension
av: M. M. Beraya, et al.
Publicerad: (2007-02-01)

Pathogenesis of arterial hypertension within the metabolic syndrome
av: A S Ryazanov, et al.
Publicerad: (2003-03-01)

Antihypertensive spirapril effectiveness in patients with mild to moderate arterial hypertension
av: M. M. Beraya, et al.
Publicerad: (1970-01-01)

Imidazoline receptor agonist moxonidine and arterial hypertension treatment in women with menopausal metabolic syndrome
av: E. V. Tishina, et al.
Publicerad: (2011-06-01)

Moxonidine for arterial hypertension treatment in menopausal women with metabolic syndrome
av: V. V. Trusov, et al.
Publicerad: (2007-08-01)

AFFECTIVE DISORDERS IN MEN WITH ARTERIAL HYPERTENSION IN COMBINATION WITH METABOLIC SYNDROME
av: Roman A. Yaskevich, et al.
Publicerad: (2022-08-01)

AFFECTIVE DISORDERS IN WOMEN WITH ARTERIAL HYPERTENSION IN COMBINATION WITH METABOLIC SYNDROME
av: Roman A. Yaskevich, et al.
Publicerad: (2022-06-01)

The efficacy of available supplements and medical drugs in longevity medicine - a review
av: Michał Łata, et al.
Publicerad: (2025-01-01)

SHIFTWORK AS ONE OF RISK FACTORS OF ARTERIAL HYPERTENSION AND METABOLIC DISORDERS
av: I. S. Dzherieva, et al.
Publicerad: (2015-12-01)

Advantages of telmisartan pharmacotherapy in elderly patients with arterial hypertension and metabolic syndrome who have suffered an ischemic stroke
av: O. A. Osipova, et al.
Publicerad: (2022-10-01)